INCY
NASDAQ · Biotechnology
Incyte Corp
$98.56
+0.79 (+0.81%)
Performance
1D
—
1W
—
1M
—
3M
-9.60%
6M
-8.88%
1Y
+61.97%
YTD
-2.82%
Open$98.60
Previous Close$97.77
Day High$99.87
Day Low$97.47
52W High$112.29
52W Low$57.77
Volume—
Avg Volume1.59M
Market Cap19.65B
P/E Ratio15.28
EPS$6.40
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$101.74
Below
SMA 200
$86.15
Above
RSI (14)
51.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
33 analysts
Price Target
+109.8% upside
Current
$98.56
$98.56
Target
$206.81
$206.81
$125.25
$206.81 avg
$260.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.11B | 4.45B | 3.83B |
| Net Income | 1.28B | 1.00B | -346,012,622 |
| Profit Margin | 25.0% | 23.8% | -9.0% |
| EBITDA | 1.56B | 1.29B | -409,317,505 |
| Free Cash Flow | — | — | -346,886,835 |
| Rev Growth | +14.8% | +14.8% | -9.6% |
| Debt/Equity | 0.01 | 0.01 | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |